Direct bacterial killing in vitro by recombinant Nod2 is compromised by crohn's disease-associated mutations

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Perez, Laurent Herve ^a   Butler, Matt ^a   Creasey, Tammy ^a   Dzink Fox, Joann ^a   Gounarides, John ^a   Petit, Stephanie ^a   Ropenga, Anna ^a   Ryder, Neil ^a   Smith, Kathryn ^a   Smith, Philip ^a   Parkinson, Scott J ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CIPROFLOXACIN; PATTERN RECOGNITION RECEPTOR;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL METABOLISM; BACTERICIDAL ACTIVITY; CAUSAL ATTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS);

EID: 77955217883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010915     Document Type: Article

References (39)

1. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.
2. Cho J (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8: 458-66.
3. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser A-L, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
4. Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640.
5. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, et al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823.
6. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
7. Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A (2008) Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol 24: 440-447.
8. +. J Bacteriol 180: 4314-4318.
9. Bearson S, Bearson B, Foster JS (1997) Acid stress responses in enterobacteria. FEMS Microbiol Lett 147: 173-180.
10. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, et al. (2003) CARD15/NOD2 functions as an anti-bacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993-1000.
11. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
12. Meinzer U, Esmiol-Welterlin S, Barreau F, Berrebi D, Dussaillant M, et al. (2008) Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice. PLoS One 3: e2769.
13. Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, et al. (2008) Nod2- deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 161: 7157-7165.
14. Nuding S, Fellerman K, Wehkamp J, Mueller HA, Stange EF (2005) A flow cytometric assay to monitor anti-microbial activity of defensins and cationic tissue extracts. J Microbiol Methods 65: 335-345.
15. Zasloff M (2002) Anti-microbial peptides of multicellular organisms. Nature 415: 389-395.
16. Gareau MG, Silva MA, Perdue MH (2008) Pathophysiological mechanisms of stress-induced intestinal damage. Current Molecular Medicine 8: 274-281.
17. Cameron HL, Perdue MH (2005) Stress impairs murine intestinal barrier function: improvement by Glucagon-like peptide-2. J Pharmacol Exp Ther 314: 214-220.
18. Miceli-Richard C, Lesage S, Rybojad M, Prieur A-M, Manouvrier-Hanu S, et al. (2001) CARD15 mutations in Blau syndrome. Nature Genet 29: 19-20.
19. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, et al. (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappa-B activation: common genetic etiology with Blau syndrome. Blood 105: 1195-1197.
20. Travassos LH, Carneiro LA, Girardin SE, Boneca IG, Lemos R, et al. (2005) Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J Biol Chem 280: 36714-36718.
21. Vinzing M, Eitel J, Lippmann J, Hocke AC, Zahlten J, et al. (2008) NAIP and Ipaf control Legionella pneumophila replication in human cells. J Immunol 180: 6808-15.
22. Scharf JM, Damron D, Frisella A, Bruno S, Beggs AH, et al. (1996) The mouse region syntenic for human spinal muscular atrophy lies within the Lgn1 critical interval and contains multiple copies of Naip exon 5. Genomics 38: 405-17.
23. Austin CM, Ma X, Graviss EA (2008) Common nonsynonymous polymorphisms in the NOD2 Gene are associated with resistance or susceptibility to Tuberculosis disease in African Americans. J Infect Dis 197: 1713-1716.
24. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, et al. (2009) Genomewide association study of Leprosy. N Engl J Med 361: 2609-2618.
25. Ferwerda G, Kullberg BJ, de Jong DJ, Girardin SE, Langenberg DML, et al. (2007) Mycobacterium paratuberculosis is recognized by toll-like receptors and Nod2. J Leuk Bio 82: 1011-1018.
26. Bochud P-Y, Hawn TR, Aderem A (2003) A Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immun 170: 3451-3454.
27. Pierce ES (2009) Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog 5: e1000234.
28. Nasser SA (2005) Mycobacterium in Crohn's disease is hard to digest. Gastroenterology 129: 1359-61.
29. Sechi, LA, Scanu AM, Molicotti P, Cannas S, Mura M, et al. (2005) Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am J Gastroenterol 100: 1537-8.
30. Lees CW, Satsangi J (2009) Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol 3: 513-534.
31. Intemann CD, Thye T, Niemann S, Browne EN, Chinbuah M, et al. (2009) Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. Africanum strains. PLoS Pathog 5: e1000577.
32. DeYoung BJ, Innes RW (2006) Plant NBS-LRR proteins in pathogen sensing and host defense. Nature Immunology 7: 1243-1249.
33. Herrin BR, Alder MN, Roux KH, Sina C, Ehrhardt GRA, et al. (2008) Structure and specificity of lamprey monoclonal antibodies. Proc Natl Acad Sci USA 105: 2040-2045.
34. Pancer Z, Amemiya CT, Ehrhardt GRA, Ceitlin J, Gartland GL, et al. (2004) Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430: 174-180.
35. Alder MN, Rogozin IB, Iyer LM, Glazko GV, Cooper MD, et al. (2005) Diversity and function of adaptive immune receptors in a jawless vertebrate. Science 310: 1970-1973.
36. Nagawa F, Kishishita N, Shimizu K, Hirose S, Miyoshi M, et al. (2007) Antigenreceptor genes of the agnathan lamprey are assembled by a process involving copy choice. Nature Immunology 8: 206-213.
37. National committee for Clinical Laboratory Standards. Methods for dilution anti-microbial susceptibility tests for bacteria that grow aerobically; Approved standard ã sixth edition. NCCLS document M7-A6, NCCLS, Wayne, PA.
38. Lin CY, Wu H, Tjeerdema RS, Viant MR (2007) Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3: 55-67.
39. Fan TW (1996) Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Progress in Nuclear Magnetic Resonance Spectroscopy 28: 161-219.